Oncotelic Therapeutics (OTLC) Other Non-Current Liabilities (2010 - 2026)
Oncotelic Therapeutics (OTLC) reported Other Non-Current Liabilities of $2.63 million for Q2 2026, unchanged from $2.63 million a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
At the end of FY2025, Oncotelic Therapeutics posted Other Non-Current Liabilities of $1 million, up 42.0% from FY2024.
- Other Non-Current Liabilities has a five-year compound annual growth rate of -17.4% (FY2020 to FY2025).
- By year, Other Non-Current Liabilities came in at $704,000 in FY2024 (-72.9%), $2.6 million in FY2023, $162,500 in FY2022 (-93.8%) and $2.6 million in FY2021 (unchanged).
- Year over year, Other Non-Current Liabilities gained in 1 of the last seven quarters, with an average decline of 4.4%.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q3 2021 (growth of 235.1%); the low point was Q4 2022 (a decline of 93.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn |
| 10 | Oncotelic Therapeutics | 5.77 Mn | 4.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.63 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 2.63 Mn |
| Jun 30, 2025 | 2.63 Mn |
| Mar 31, 2025 | 2.63 Mn |
| Dec 31, 2024 | 704,000.00 |
| Sep 30, 2024 | 2.63 Mn |
| Jun 30, 2024 | 2.63 Mn |
| Mar 31, 2024 | 2.63 Mn |
| Dec 31, 2023 | 2.60 Mn |
| Sep 30, 2023 | 2.63 Mn |
| Jun 30, 2023 | 2.63 Mn |
| Mar 31, 2023 | 2.63 Mn |
| Dec 31, 2022 | 162,500.00 |
| Sep 30, 2022 | 2.63 Mn |
| Jun 30, 2022 | 2.63 Mn |
| Mar 31, 2022 | 2.60 Mn |
| Dec 31, 2021 | 2.60 Mn |
| Sep 30, 2021 | 2.60 Mn |
| Jun 30, 2021 | 2.60 Mn |
API Access
Oncotelic Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();